Integer (NYSE: ITGR) is one of 25 public companies in the “Miscellaneous electrical machinery, equipment, & supplies” industry, but how does it compare to its competitors? We will compare Integer to related businesses based on the strength of its valuation, dividends, earnings, risk, analyst recommendations, institutional ownership and profitability.
Risk and Volatility
Integer has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Comparatively, Integer’s competitors have a beta of 0.76, suggesting that their average stock price is 24% less volatile than the S&P 500.
This table compares Integer and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings and target prices for Integer and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Integer currently has a consensus price target of $51.00, indicating a potential downside of 8.03%. As a group, “Miscellaneous electrical machinery, equipment, & supplies” companies have a potential upside of 27.76%. Given Integer’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Integer has less favorable growth aspects than its competitors.
Valuation & Earnings
This table compares Integer and its competitors revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Integer||$1.46 billion||$66.67 million||19.73|
|Integer Competitors||$793.44 million||$37.39 million||5.56|
Integer has higher revenue and earnings than its competitors. Integer is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Institutional & Insider Ownership
95.8% of Integer shares are owned by institutional investors. Comparatively, 44.4% of shares of all “Miscellaneous electrical machinery, equipment, & supplies” companies are owned by institutional investors. 4.8% of Integer shares are owned by company insiders. Comparatively, 17.3% of shares of all “Miscellaneous electrical machinery, equipment, & supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Integer beats its competitors on 7 of the 13 factors compared.
Integer Company Profile
Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare’s challenges and reflects the Company’s strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.